Data are mean SEM from WT and Bbs5 / mice
For weight loss, name-brand semaglutide (Wegovy) comes in six FDA-approved doses for weekly injection (0.25, 0.5, 1, 1.7, 2.4, and 7.2 mg) and four FDA-approved oral doses for daily ingestion (1.5, 4, 9, and 25 mg)
A human endothelial cell-based recycling assay for screening of FcRn targeted molecules
SPPS (Solid-Phase Peptide Synthesis): This is the most common approach to upstream peptide manufacturing
Focus on GLP-1 drugs & eye problems Im following a number of problems associated with GLP-1 drugs for overweight, obesity or Type 2 diabetes
Wootten D, Reynolds CA, Smith KJ et al (2016) The extracellular surface of the GLP-1 receptor is a molecular trigger for biased agonism